Granules India Q2 PAT seen up 4.4% YoY to Rs. 40 cr: HDFC Securities

HDFC Securities has come out with its second quarter (July-September’ 18) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Granules India to report net profit at Rs. 40 crore up 4.4% year-on-year (down 18.7% quarter-on-quarter).

Net Sales are expected to increase by 18.5 percent Y-o-Y (up 2.6 percent Q-o-Q) to Rs. 470 crore, according to HDFC Securities.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 0.9 percent Y-o-Y (up 6.9 percent Q-o-Q) to Rs. 80 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.